Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.

PubWeight™: 6.38‹?› | Rank: Top 1%

🔗 View Article (PMID 4350926)

Published in Science on June 29, 1973

Authors

R Ross, J A Glomset

Articles citing this

(truncated to the top 100)

A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94

Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest (2009) 4.12

A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86

Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest (2006) 3.76

Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol (1976) 3.48

Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A (1981) 3.31

The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am J Pathol (1981) 3.26

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04

Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol (1982) 2.22

Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest (1986) 2.09

Response to injury and atherogenesis. Am J Pathol (1977) 2.09

Hypertension and arterial development. Long-term considerations. Br Heart J (1978) 2.03

Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J Cell Biol (1975) 1.93

The role of cytoskeletal and cytocontractile elements in pathologic processes. Am J Pathol (1983) 1.91

An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J Cell Biol (1985) 1.83

Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol (1979) 1.82

Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A (2003) 1.70

Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci U S A (1987) 1.64

Proteoglycans in primate arteries. II. Synthesis and secretion of glycosaminoglycans by arterial smooth muscle cells in culture. J Cell Biol (1975) 1.60

The aortic intima. II. Repair of the aortic lining after mechanical denudation. Am J Pathol (1975) 1.59

A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J (1988) 1.59

Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol (1993) 1.58

The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest (1977) 1.58

The three-dimensional micro- and nanostructure of the aortic medial lamellar unit measured using 3D confocal and electron microscopy imaging. Matrix Biol (2007) 1.56

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention. Heart (2011) 1.56

The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J Biol Chem (2006) 1.48

Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab (2010) 1.45

Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. J Clin Invest (1985) 1.44

Pathologic aspects of cirrhosis. A review. Am J Pathol (1977) 1.41

Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.37

Clonal characteristics of fibrous plaques and fatty streaks from human aortas. Am J Pathol (1975) 1.37

Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res (2009) 1.35

Intimal healing. The pattern of reendothelialization and intimal thickening. Am J Pathol (1977) 1.33

Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis. Proc Natl Acad Sci U S A (2013) 1.30

Thrombosis induced in vivo in the mesenteric artery of normal and thrombocytopenic rats, an electron-microscopic study of the early arterial wall reaction. Br J Exp Pathol (1977) 1.29

Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture. J Cell Biol (1981) 1.28

Maternal protein restriction in the rat impairs resistance artery but not conduit artery function in pregnant offspring. J Physiol (2002) 1.27

Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med (2012) 1.26

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res (2016) 1.20

Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol (2005) 1.19

Effect of regenerated endothelium on lipid accumulation in the arterial wall. Proc Natl Acad Sci U S A (1977) 1.19

Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J (1985) 1.17

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group. J Cell Biol (1986) 1.15

Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am J Pathol (1993) 1.15

Biosynthesis of type I and III collagens by cultured smooth muscle cells from human aorta. Proc Natl Acad Sci U S A (1977) 1.14

Overloading human aortic smooth muscle cells with low density lipoprotein-cholesteryl esters reproduces features of atherosclerosis in vitro. J Clin Invest (1977) 1.12

Unusual lysosomes in aortic smooth muscle cells: presence in living and rapidly frozen cells. J Cell Biol (1986) 1.12

Women and coronary artery disease. Part I: basic considerations. J Tehran Heart Cent (2011) 1.11

Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol (1975) 1.11

Role of endothelium and hypercholesterolemia in intimal thickening and lipid accumulation. Am J Pathol (1979) 1.09

Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol (1977) 1.09

Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol (1993) 1.09

Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents. Proc Natl Acad Sci U S A (1974) 1.08

Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J Clin Invest (1980) 1.07

Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations. Am J Pathol (1985) 1.07

Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol (1992) 1.07

Inappropriate production of collagen and prolyl hydroxylase by human breast cancer cells in vivo. Br J Cancer (1975) 1.05

Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1989) 1.05

Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol (2012) 1.05

Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med (1986) 1.05

Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest (1996) 1.04

Hepatic cirrhosis--a collagen formative disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 1.04

Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch (2010) 1.04

Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int (2014) 1.03

Collagen biosynthesis in nonfibroblastic cell lines. Proc Natl Acad Sci U S A (1974) 1.01

Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers. Proc Natl Acad Sci U S A (1991) 1.01

Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect Immun (1999) 1.01

P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signal (2012) 1.00

Lipid accumulation in smooth muscle cell lysosomes im primate atherosclerosis. Am J Pathol (1975) 1.00

Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985). Front Cardiovasc Med (2014) 0.99

P2 receptors and platelet function. Purinergic Signal (2011) 0.98

Lost in transdifferentiation. J Clin Invest (2004) 0.98

Restitution of aortic wall after sustained necrotizing transmural ligation injury. Role of blood cells and artery cells. Am J Pathol (1975) 0.96

Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol (2012) 0.96

Characterization of bone PG II cDNA and its relationship to PG II mRNA from other connective tissues. Nucleic Acids Res (1986) 0.96

Clonal characteristics of cutaneous scars and implications for atherogenesis. Am J Pathol (1981) 0.96

MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. Circ Res (2012) 0.95

Effect of endothelium on glycosaminoglycan accumulation in injured rabbit aorta. Am J Pathol (1983) 0.95

cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun (2001) 0.94

Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol (1993) 0.93

Age-related vascular stiffening: causes and consequences. Front Genet (2015) 0.93

Thrombosis induced in vivo in the femoral artery of rats. An electron microscopic study of myointimal growth. Br J Exp Pathol (1979) 0.93

Glucocorticoids stimulate collagen and noncollagen protein synthesis in cultured vascular smooth muscle cells. J Cell Biol (1984) 0.93

The human atherosclerotic plaque. Am J Pathol (1977) 0.92

Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One (2012) 0.92

Oxidative mechanisms and atherothrombotic cardiovascular disease. Drug Discov Today Ther Strateg (2008) 0.90

Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90

Effect of occlusion on large vessels. I. A study of the rat carotid artery. Am J Pathol (1977) 0.90

Periodontitis as a risk factor of atherosclerosis. J Immunol Res (2014) 0.88

12/15-Lipoxygenase mediates high-fat diet-induced endothelial tight junction disruption and monocyte transmigration: a new role for 15(S)-hydroxyeicosatetraenoic acid in endothelial cell dysfunction. J Biol Chem (2013) 0.87

Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. IX. Specific inhibition of DNA synthesis initiation by very low density lipoprotein and possible significance to the problem of liver regeneration. J Cell Biol (1976) 0.87

Enzyme activities in endothelial cells and smooth muscle cells from swine aorta. Proc Natl Acad Sci U S A (1979) 0.87

Smooth muscle cell proliferation in the occluded rat carotid artery: lack of requirement for luminal platelets. Am J Pathol (1979) 0.87

The clonal characteristics of human aortic intima. Comparison with fatty streaks and normal media. Am J Pathol (1983) 0.86

Effect of hypoxia and carbon monoxide on collagen synthesis in cultured porcine and bovine aortic endothelium. Br J Exp Pathol (1985) 0.85

Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772. J Biol Chem (2013) 0.85

Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias. Acta Pharmacol Sin (2010) 0.85

Articles by these authors

The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59

The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72

A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb (1994) 8.54

The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res (1968) 8.11

The biology of platelet-derived growth factor. Cell (1986) 7.17

Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76

The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol (1975) 6.42

The pathogenesis of atherosclerosis (second of two parts). N Engl J Med (1976) 5.48

Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) (2000) 5.24

The pathogenesis of atherosclerosis (first of two parts). N Engl J Med (1976) 5.22

The smooth muscle cell in culture. Physiol Rev (1979) 5.03

Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) (1998) 5.01

A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell (1985) 4.81

The platelet-derived growth factor. Cell (1978) 4.77

The elastic fiber. I. The separation and partial characterization of its macromolecular components. J Cell Biol (1969) 4.51

Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51

Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40

Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27

A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86

The fibroblast and wound repair. Biol Rev Camb Philos Soc (1968) 3.78

The fine structure of elastic fibers. J Cell Biol (1966) 3.68

Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol (1998) 3.66

Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59

Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54

Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol (1976) 3.48

Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem (1982) 3.35

Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33

Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) (2000) 3.31

Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem (1982) 3.20

Wound healing and collagen formation. V. Quantitative electron microscope radioautographic observations of proline-H3 utilization by fibroblasts. J Cell Biol (1965) 3.18

Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med (1972) 3.17

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04

PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol (1990) 3.04

Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98

Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell (1982) 2.92

HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91

Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res (1988) 2.90

TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82

Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components. Proc Natl Acad Sci U S A (1978) 2.80

Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem (1981) 2.77

The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol (1971) 2.74

Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr (2000) 2.71

Human lamin B contains a farnesylated cysteine residue. J Biol Chem (1989) 2.71

Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70

Development and testing of nursing home quality indicators. Health Care Financ Rev (1995) 2.68

The development of the rat flexor digital tendon, a fine structure study. J Ultrastruct Res (1967) 2.61

Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci U S A (1984) 2.58

Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55

Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell (1996) 2.55

Hyperlipidemia and atherosclerosis. Science (1976) 2.55

Human wound repair. I. Epidermal regeneration. J Cell Biol (1968) 2.39

Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 2.38

Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol (1981) 2.33

Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A (1993) 2.31

Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell (1998) 2.29

Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol (1984) 2.29

Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27

Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst (1986) 2.27

Brain G protein gamma subunits contain an all-trans-geranylgeranylcysteine methyl ester at their carboxyl termini. Proc Natl Acad Sci U S A (1990) 2.26

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23

Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A (1986) 2.20

Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J Cell Biol (1978) 2.16

Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13

The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res (1973) 2.12

Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol (1968) 2.11

Evidence for modification of lamin B by a product of mevalonic acid. J Biol Chem (1988) 2.09

Response to injury and atherogenesis. Am J Pathol (1977) 2.09

Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod (2010) 2.07

Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A. Cell (1981) 2.06

Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A (1988) 2.06

Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01

Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98

Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest (1994) 1.97

The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest (1972) 1.96

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A (1992) 1.94

Effects of antimicrotubular agents on the secretion of collagen. A biochemical and morphological study. J Cell Biol (1974) 1.93

An endothelial cell-derived growth factor. J Cell Biol (1980) 1.93

Economic status and survival of cancer patients. Cancer (1977) 1.93

Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J Cell Biol (1975) 1.93

George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis (1982) 1.90

Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90

Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88

Identification of geranylgeranyl-modified proteins in HeLa cells. Science (1990) 1.88

Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell (1998) 1.87

Physiological quiescence in plasma-derived serum: influence of platelet-derived growth factor on cell growth in culture. J Cell Physiol (1978) 1.85

Protein geranylgeranyltransferase of Saccharomyces cerevisiae is specific for Cys-Xaa-Xaa-Leu motif proteins and requires the CDC43 gene product but not the DPR1 gene product. Proc Natl Acad Sci U S A (1991) 1.83

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation (1992) 1.82

Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labeling. J Biol Chem (1982) 1.79

Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79

The elastic fiber. J Histochem Cytochem (1973) 1.79

Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med (1994) 1.78

Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J Biol Chem (1984) 1.77

Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol (1970) 1.77

Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol (1999) 1.70

C terminus of the small GTP-binding protein smg p25A contains two geranylgeranylated cysteine residues and a methyl ester. Proc Natl Acad Sci U S A (1991) 1.69

Interactions between the receptors for platelet-derived growth factor and epidermal growth factor. J Cell Biol (1983) 1.68